SecBot SecBot
144 ·Filed Nov 6, 2026

BMY

BRISTOL MYERS SQUIBB CO
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 12h ago SEC0001628280-26-071514
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a small sale by a director. No material impact expected; monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$62.14
T+0 close · Nov 6, 2026 · via day close
Latest settled
+2.08%
T+5 · $63.43
Vs SPY
−0.52%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $62.14entry
  2. T+1 · 8d ago 0.00%α −2.37% · $62.14
  3. T+5 · 4d ago +2.08%α −0.52% · $63.43
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Julia A. Haller filed a Form 144 notice of intent to sell 3,800 shares of Bristol Myers Squibb common stock, with an approximate market value of $250,000. The sale represents a small fraction of her total holdings and the company's $131B market cap, making it a routine insider diversification move.

Key Facts

  • Insider: Julia A. Haller, Director
  • Shares to be sold: 3,800 shares of common stock
  • Approximate value: $250,000
  • Date of proposed sale: 11/05/2026
  • Shares acquired on 06/13/2021 (stock bonus) and 06/03/2022 (stock bonus)
  • Broker: Merrill Lynch

Financial Impact

Sale of 3,800 shares valued at ~$250,000, representing less than 0.0003% of BMY's $131.2B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell, not a completed transaction; the sale may not occur
  • No unusual insider selling pattern detected; this appears to be a routine diversification trade

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (34 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-071514
Document: 0001628280-26-071514-index.html0001628280-26-071514
Document: 0001628280-26-071514.txt0001628280-26-071514

Track record

9 reports on BMY

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +6.33% at T+20 after the Aug 5, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $62.14 to $62.14 Now $62.93 +1.27% · 0.00% −2.37% vs SPY
  2. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $61.39 to $62.48 Now $62.93 +2.51% ▲ +1.78% +3.55% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $61.48 to $61.61 Now $62.93 +2.36% ▲ +0.21% −0.50% vs SPY
  4. Oct 5, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
  5. Aug 17, 202613w ago Institutional Cluster Bullish 6/10 Entry $64.63 to $66.05 Now $62.93 −2.63% ▲ +2.20% +2.87% vs SPY
  6. Aug 5, 202614w ago ANALYST-UPGRADE Bullish 4/10 Entry $63.63 to $64.15 Now $62.93 −1.10% ▲ +0.82% +0.98% vs SPY
  7. Jul 30, 202615w ago 8-K Bullish 7/10 Entry $64.86 to $65.31 Now $62.93 −2.98% ▲ +0.69% −0.01% vs SPY
  8. Mar 25, 202633w ago DEFA14A Neutral 3/10 Entry $59.39 to $58.47 Now $62.93 +5.97% ▼ −1.55% +0.13% vs SPY
  9. Feb 26, 202637w ago Court Ruling Neutral 3/10 Entry $62.37 to $62.34 Now $62.93 +0.90% ▼ −0.05% −0.10% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 7h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026